Walleye Trading’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.25M | Sell |
14,700
-13,500
| -48% | -$2.07M | ﹤0.01% | 1639 |
|
|
2025
Q4 | $3.89M | Buy |
28,200
+15,800
| +127% | +$2.07M | 0.01% | 1449 |
|
|
2025
Q3 | $1.59M | Sell |
12,400
-5,400
| -30% | -$659K | ﹤0.01% | 1962 |
|
|
2025
Q2 | $2.15M | Buy |
17,800
+1,500
| +9% | +$169K | ﹤0.01% | 1679 |
|
|
2025
Q1 | $1.82M | Sell |
16,300
-35,000
| -68% | -$3.73M | ﹤0.01% | 1698 |
|
|
2024
Q4 | $4.99M | Buy |
51,300
+2,200
| +4% | +$235K | 0.01% | 1144 |
|
|
2024
Q3 | $5.65M | Buy |
49,100
+24,500
| +100% | +$2.78M | 0.01% | 1069 |
|
|
2024
Q2 | $2.62M | Sell |
24,600
-3,500
| -12% | -$351K | 0.01% | 1439 |
|
|
2024
Q1 | $2.72M | Sell |
28,100
-38,100
| -58% | -$3.91M | 0.01% | 1534 |
|
|
2023
Q4 | $6.68M | Sell |
66,200
-13,900
| -17% | -$1.34M | 0.01% | 1057 |
|
|
2023
Q3 | $8.16M | Sell |
80,100
-151,100
| -65% | -$15.3M | 0.02% | 784 |
|
|
2023
Q2 | $23.3M | Sell |
231,200
-297,700
| -56% | -$29.8M | 0.07% | 252 |
|
|
2023
Q1 | $48.7M | Buy |
528,900
+75,600
| +17% | +$6.6M | 0.11% | 148 |
|
|
2022
Q4 | $41.1M | Buy |
453,300
+163,500
| +56% | +$13.8M | 0.12% | 167 |
|
|
2022
Q3 | $22M | Buy |
289,800
+246,500
| +569% | +$20.4M | 0.07% | 291 |
|
|
2022
Q2 | $3.66M | Sell |
43,300
-165,800
| -79% | -$14.5M | 0.01% | 1219 |
|
|
2022
Q1 | $18.3M | Sell |
209,100
-64,100
| -23% | -$5.55M | 0.06% | 377 |
|
|
2021
Q4 | $23.9M | Buy |
273,200
+141,200
| +107% | +$11.7M | 0.08% | 256 |
|
|
2021
Q3 | $10.8M | Buy |
132,000
+130,300
| +7,665% | +$11.7M | 0.04% | 514 |
|
|
2021
Q2 | $155K | Sell |
1,700
-300
| -15% | -$26.7K | ﹤0.01% | 4118 |
|
|
2021
Q1 | $171K | Sell |
2,000
-55,500
| -97% | -$4.98M | ﹤0.01% | 3757 |
|
|
2020
Q4 | $5.43M | Sell |
57,500
-18,400
| -24% | -$1.61M | 0.02% | 682 |
|
|
2020
Q3 | $6.6M | Buy |
75,900
+62,600
| +471% | +$5.42M | 0.04% | 444 |
|
|
2020
Q2 | $1.16M | Sell |
13,300
-4,800
| -27% | -$414K | 0.01% | 1530 |
|
|
2020
Q1 | $1.49M | Sell |
18,100
-21,100
| -54% | -$1.88M | 0.01% | 1025 |
|
|
2019
Q4 | $3.71M | Sell |
39,200
-14,000
| -26% | -$1.26M | 0.03% | 767 |
|
|
2019
Q3 | $4.62M | Buy |
53,200
+21,100
| +66% | +$1.89M | 0.04% | 504 |
|
|
2019
Q2 | $2.93M | Buy |
32,100
+16,030
| +100% | +$1.36M | 0.03% | 776 |
|
|
2019
Q1 | $1.38M | Buy |
16,070
+4,464
| +38% | +$358K | 0.01% | 1370 |
|
|
2018
Q4 | $892K | Sell |
11,606
-447
| -4% | -$34.8K | 0.01% | 1843 |
|
|
2018
Q3 | $931K | Buy |
12,053
+7,701
| +177% | +$569K | ﹤0.01% | 2154 |
|
|
2018
Q2 | $295K | Sell |
4,352
-12,500
| -74% | -$863K | ﹤0.01% | 3309 |
|
|
2018
Q1 | $1.22M | Sell |
16,852
-10,602
| -39% | -$807K | 0.01% | 1722 |
|
|
2017
Q4 | $2.06K | Sell |
27,454
-3,013
| -10% | -$227K | 0.01% | 1281 |
|
|
2017
Q3 | $2.35K | Sell |
30,467
-15,959
| -34% | -$1.21M | 0.01% | 1156 |
|
|
2017
Q2 | $3.47K | Buy |
46,426
+38,168
| +462% | +$2.71M | 0.02% | 809 |
|
|
2017
Q1 | $549 | Sell |
8,258
-12,500
| -60% | -$833K | ﹤0.01% | 2159 |
|
|
2016
Q4 | $1.35M | Sell |
20,758
-17,744
| -46% | -$1.15M | 0.01% | 1275 |
|
|
2016
Q3 | $2.72M | Buy |
38,502
+18,749
| +95% | +$1.37M | 0.02% | 751 |
|
|
2016
Q2 | $1.47M | Buy |
19,753
+4,352
| +28% | +$301K | 0.01% | 1259 |
|
|
2016
Q1 | $999K | Buy |
15,401
+781
| +5% | +$53.1K | 0.01% | 1402 |
|
|
2015
Q4 | $1.13M | Sell |
14,620
-7,030
| -32% | -$558K | 0.01% | 1148 |
|
|
2015
Q3 | $1.78M | Buy |
21,650
+2,008
| +10% | +$179K | 0.02% | 722 |
|
|
2015
Q2 | $1.73M | Buy |
19,642
+13,504
| +220% | +$1.24M | 0.02% | 782 |
|
|
2015
Q1 | $542K | Sell |
6,138
-21,539
| -78% | -$1.91M | 0.01% | 1427 |
|
|
2014
Q4 | $2.3M | Buy |
27,677
+3,906
| +16% | +$324K | 0.02% | 620 |
|
|
2014
Q3 | $2.01M | Buy |
23,771
+6,361
| +37% | +$515K | 0.02% | 450 |
|
|
2014
Q2 | $1.41K | Buy |
17,410
+1,116
| +7% | +$87.8K | 0.02% | 598 |
|
|
2014
Q1 | $1.25K | Sell |
16,294
-1,785
| -10% | -$130K | 0.02% | 721 |
|
|
2013
Q4 | $1.3M | Buy |
18,079
+17,409
| +2,598% | +$1.21M | 0.01% | 927 |
|
|
2013
Q3 | $46K | Sell |
670
-46,090
| -99% | -$3.05M | ﹤0.01% | 2294 |
|
|
2013
Q2 | $2.96M | Buy |
+46,760
| New | +$3.04M | 0.03% | 442 |
|
Other funds holding NVS
Walleye Trading's NVS Position: Q1 2026 in Review
Walleye Trading opened a new position in Novartis (NVS) in Q1 2026: 839 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #3342 among its holdings. This is a return to the name: Walleye Trading previously reported a position in NVS as recently as Q3 2025.
Walleye Trading first reported a position in NVS in Q1 2015 and has held it in 21 quarters since. The position peaked at $4.83M in Q3 2023. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Walleye Trading held 839 shares of Novartis worth $128K as of Q1 2026.
- Novartis was a new Walleye Trading position in Q1 2026.
- Novartis made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3342 holding.
- Walleye Trading first reported a position in Novartis in Q1 2015 and has held it in 21 quarters since.
- Walleye Trading's Novartis position peaked at $4.83M in Q3 2023.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.